AI, Early Access, and Specialty Infusion: Inside CommonSpirit Health at Home's 2026 Playbook
CommonSpirit Health at Home is pressing forward with a simple thesis: move care earlier, use AI with intent, and focus infusion on where it matters most. The organization operates 94 home health, hospice, palliative, and home infusion locations across the U.S., serving as the home-based care arm of CommonSpirit Health.
President and CEO Trisha Crissman is clear about the shift. Late referrals from acute settings have led to hospice admissions where patients pass away far too soon after entry. The fix is upstream access and smarter identification.
Move Care Upstream: From Late Referrals to Early Eligibility
The new model leans into physician enterprises, specialty clinics, and ambulatory centers. Eligibility triggers inside the EHR surface candidates before the next exacerbation, and in-clinic navigators close the loop with patients and caregivers.
The expected outcome: earlier access to hospice and home health, fewer acute episodes, and less friction for physicians who carry the weight of eligibility decisions. Give people support sooner, and everything else tends to improve.
- Where it happens: physician practices, specialty clinics, ambulatory sites
- How it happens: EHR-based triggers + trained navigators in clinics
- Why it works: earlier intervention, clearer conversations, better outcomes
AI With Discipline, Not Hype
"AI, AI and AI." The opportunity is massive, and the temptation is to buy everything at once. CommonSpirit Health at Home is taking the opposite path: pick the highest-impact use cases, execute incrementally, and avoid "boiling the ocean."
- Priority use cases: predictive eligibility signals, care workflow automation, and smarter resource allocation
- Guardrails: measurable ROI, clinical safety, equity, data privacy, and auditable models
- Experience first: design for patients, caregivers, and clinicians-not just efficiency metrics
For leaders building a pragmatic roadmap, this is the play: focus on outcomes you can measure, then scale what proves out. If you need a primer on executive-level AI decision-making, see AI for Executives & Strategy.
Home Infusion: A Shift to Specialty and Chronic Therapies
The organization is repositioning home infusion around specialty and chronic therapies. Expect a 12-24 month build, with the goal of deeper clinical value and stronger economics.
Being part of a national health system opens doors-supply chain leverage, referral alignment, data sharing, and consistent clinical standards. The bet is that a focused infusion portfolio outperforms a broad, unfocused one.
Growth Agenda: Full-Continuum Coverage, Market by Market
A five-year plan is in motion to expand in current markets and enter new ones. The strategy ties home health, hospice, palliative, and infusion into one continuum, with physician enterprise integration as the connective tissue.
The interlock between home health and hospice is a core advantage: earlier identification feeds the right service at the right time, and patients don't fall through the cracks between episodes of care.
What Executive Teams Can Use Today
- Move earlier: embed EHR triggers and navigators inside clinics to surface eligibility before the next acute event.
- Adopt AI in steps: start with a narrow set of high-yield use cases, prove outcomes, then scale.
- Refocus service lines: specialize where clinical value and payer alignment are strongest (e.g., specialty infusion).
- Tighten the continuum: link home health, hospice, and palliative so referrals are timely and transitions are clean.
- Leverage system scale: use enterprise relationships for data, contracting, and standardization you can't get alone.
The takeaway is straightforward. Earlier access, disciplined AI, and focused service lines compound. Do that consistently, and the ceiling moves higher every quarter.
Your membership also unlocks:
